GLP‑1 supply: know what is left.
Supply is the quiet part of a GLP‑1 routine. Pens run out, vials reach their in-use limit and refills take time. A count you can see, kept beside the doses, turns a surprise into a conversation you can start early.
Count what you have
Supply is not one number. A box may hold four weekly pens; a vial may hold several doses; a bottle of tablets may hold thirty. The count that matters is the number of doses you can still take, not the number of boxes in the drawer. Write the count in doses and the arithmetic stays simple.
For a multi-dose pen, the label tells you how many doses the pen holds and how long it can be used after first use. For a single-dose pen or vial, each one is one dose. For a tablet, the bottle count is the dose count. If you use a compounded vial, the concentration and the volume decide how many doses are in it; that arithmetic belongs to the pharmacy’s instructions, not to a guess.
Note the date you opened the current pen or vial. The in-use window starts then, not when the prescription was filled. A pen that has been in the refrigerator for a month is not the same as a pen that has been open for a month.
What the labels say about use
The storage windows differ by product, and they are easy to mix up. Ozempic® says the pen can be stored for 56 days at controlled room temperature or in a refrigerator after first use. The Wegovy® FlexTouch pen gives the same 56-day window after first use; its single-dose pen can be kept for up to 28 days at 8°C to 30°C before the cap comes off. Zepbound® says: “Throw away opened multi-dose vial or single-patient-use KwikPen after a total of 30 days at room temperature, 30 days after first use, or after taking 4 weekly doses, even if there is medicine left in it.” Trulicity® allows 14 days at room temperature. Saxenda® and Victoza® allow 30 days after first use.
Those numbers are limits, not deadlines to aim for. The point of writing them down is to know when a pen or vial has moved from “in date” to “past its in-use window.” A label on the box may give the expiry date, but it does not know when you opened it.
The FDA also warns about compounded products that arrive warm or with inadequate ice packs. Its guidance says: “The agency recommends patients not use any injectable GLP‑1 drug that arrives warm or with insufficient refrigeration, as this can affect the drug’s quality.” A supply count is a good place to note how a delivery arrived, especially if the same pharmacy has had a problem before.
When to start a refill
The right moment to refill is earlier than the moment you run out. How much earlier depends on the pharmacy, the insurance, the prescriber’s office and whether the medication is in stock. A count in doses lets you see the runway: at one dose a week, four pens are four weeks, and a refill that takes ten days needs to start with more than ten days left.
If you are traveling, add the days away and a margin for delays. If a dose is changing, check whether the new strength comes in the same pack size; the count may not carry over the way you expect. If the pharmacy is out of stock, the prescriber may need to send the prescription elsewhere, which takes time.
A refill conversation is easier with dates. “I have three pens left, my last dose is on the 21st, and I travel on the 28th” is more useful than “I am running low.” The log supplies the first version.
Two delays are worth planning for. The first is prior authorization: an insurer may ask the prescriber for information before it covers a refill, and that exchange can take days. The second is a strength change: a new dose may come in a different pack size, so the old count does not simply carry over. If either is possible, start the conversation earlier than the count alone suggests.
Tablets have their own supply details. The bottle count is the dose count, and the label asks for the tablets to be kept in the original bottle, away from moisture. A pill organizer is convenient, but it moves the tablets out of the packaging the label specifies. If you use one, keep the original bottle and its label, and note the date the bottle was opened. The bottle is also the place to check the strength when the pharmacy sends a refill, before the old box goes in the bin, each time.
Keep the count honest
- Record the dose when you take itThe count is only as good as the entries. A dose taken but not logged looks like supply you still have.
- Record the open dateFor a pen or vial, the in-use window starts at first use. Write it on the box if that helps.
- Record a wasted doseA pen that misfires, a broken vial, a dose spilled: note it. The count is meant to match the shelf, not the ideal.
- Record the refill dateWhen the new box arrives, update the count and the expiry. Two numbers, one line.
- Keep the label with the supplyThe storage window and the strength are on it. A photo of the label works if the box is bulky.
Max HP keeps a supply count for pens, vials and packs, and subtracts each dose as you log it. The count is a convenience, not a prescription audit. If the number on the screen and the number in the drawer disagree, the drawer is right; correct the log and carry on.
Questions
- How many doses are in a GLP‑1 pen?
- It depends on the product. A single-dose pen is one dose. A multi-dose pen holds the number of doses the label states, and it also has an in-use window after first use. The Instructions for Use for your pen gives both numbers.
- Can I use a pen after its in-use window?
- The label sets the window for a reason. If the pen is past it, ask your pharmacist or prescriber what to do. The expiry date on the box is a separate limit and does not extend the in-use window.
- When do I order a refill?
- Early enough to cover the pharmacy’s turnaround, the prescriber’s authorization and any travel. A count in doses makes that calculation possible. The exact timing is a conversation with your pharmacy.
- What if a dose arrives warm?
- The FDA says: “The agency recommends patients not use any injectable GLP‑1 drug that arrives warm or with insufficient refrigeration, as this can affect the drug’s quality.” Contact the pharmacy and report what happened. Note the delivery in your supply record.
Sources
- Ozempic® (semaglutide) prescribing information, DailyMed. Revised May 2026. Read 3 November 2026.
- Wegovy® (semaglutide) prescribing information, DailyMed. Revised June 2026. Read 3 November 2026.
- Zepbound® (tirzepatide) prescribing information, DailyMed. Revised August 2026. Read 3 November 2026.
- Trulicity® (dulaglutide) prescribing information, DailyMed. Revised March 2026. Read 3 November 2026.
- Saxenda® (liraglutide) prescribing information, DailyMed. Revised June 2026. Read 3 November 2026.
- Victoza® (liraglutide) prescribing information, DailyMed. Revised October 2025. Read 3 November 2026.
- US Food and Drug Administration, “FDA’s Concerns with Unapproved GLP‑1 Drugs Used for Weight Loss.” Content current as of 1 October 2026. Read 3 November 2026.